You are on page 1of 1
ICH Guidelines 715 the Parent Guideline. Under some circumstances if certain variations and changes are made to the product (e.g., formulation, packaging) these studies should be repeated. A systematic approach to this testing is, as appropriate, as under: © Tests on the drug substance. © Tests on the exposed drug product outside of the immediate pack; and if necessary, © Tests on the drug product in the immediate pack. © Tests on the drug product in the marketing pack. The formal labeling requirements for photolabile drug substances and drug products are established by national/regional requirements. Acceptable change is change within limits justified by the applicant. Source of Light During photostability testing it is to maintain either an appropriate contro! of temperature to minimize the effect of localized temperature changes or to maintain a dark environment unless otherwise justified. For both options the manufacturer may rely on the spectral distribution specification of the light source manufacturer. Option I: Any light source that can produce an output similar to the D65/ID65 emission standard such as an artificial daylight fluorescent lamp combining visible and ultraviolet (UV) outputs, xenon, or metal halide lamp. As defined in ISO 10977 (1993), D65 is the internationally recognized standard for outdoor daylight. ID65 is the equivalent indoor indirect daylight standard. When a light source that emits significant radiation below 320 nm is used, an appropriate filter(s) may be fitted to eliminate such radiation, Option 2: The same sample should be exposed to both the cool white fluorescent lamp as specified in ISO 10977(1993) and near ultraviolet lamp. A near UV fluorescent lamp hawing a spectral di ution from 320 nm to 400 nm with a maximum energy emission between 350 nm and 370 nm; a significant proportion of UV should be in both bands of 320 to 360 nm and 360 to 400 nm. Procedure: For confirmation, samples should be exposed to light that can provide an overall illumination of not less than 1.2 million lux hours and can emit an integrated near ultraviolet energy of not less than 200 watt hours/square meter. Direct comparisons are to be made between the drug substance and drug product. To ensure the specified light exposure is obtained, samples may be simultaneously exposed to a validated chemical actinometric system or calibrated radiometers/lux meters may be used for monitoring the duration of exposure (time). Ul O <

You might also like